Staphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores the results of the ARREST trial, which looked at adding rifampicin to standard antistaphylococcal antibiotic treatment.

ARREST: Rifampicin for Staph. aureus bacteraemia (full length)

The Trial Talk podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. We hear from world-leading experts about the studies we carry out. We delve into trials on cancer, infections and neurodegenerative diseases, explore how public and patient involvement shapes our work, and discover new ways to run smarter studies.

Share ARREST: Rifampicin for Staph. aureus bacteraemia (full length)

Sign up to save your podcasts

ARREST: Rifampicin for Staph. aureus bacteraemia (full length)

ARREST: Rifampicin for Staph. aureus bacteraemia (full length)